Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Plos One
|
November 12, 2019
How to design a dose-finding study on combined agents: Choice of design and development of R functions
Monia Ezzalfani
Statistics in Medicine
|
June 26, 2015
Dose finding with longitudinal data: simpler models, richer outcomes
Xavier Paoletti, Adélaïde Doussau, Monia Ezzalfani, et al.
Statistics in Medicine
|
September 17, 2016
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cycles
Jun Yin, Rui Qin, Monia Ezzalfani, et al.
Statistics in Medicine
|
January 22, 2013
Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities
Monia Ezzalfani, Sarah Zohar, Rui Qin, et al.
Plos One
|
September 15, 2021
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project
Monia Ezzalfani, Raphaël Porcher, Alexia Savignoni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 11, 2021
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Therapeutic Advances in Hematology
|
March 3, 2022
Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study
John Pasi, Cédric Hermans, Zalmai Hakimi, et al.
Therapeutic Advances in Hematology
|
June 7, 2023
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B:
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Clinical Pharmacology and Therapeutics
|
February 6, 2021
Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration
Olivier Le Tilly, Nicolas Azzopardi, Claire Bonneau, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial
Pierre Loap, Delphine Loirat, Frederique Berger, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Plos One
|
November 12, 2019
How to design a dose-finding study on combined agents: Choice of design and development of R functions
Monia Ezzalfani
Statistics in Medicine
|
June 26, 2015
Dose finding with longitudinal data: simpler models, richer outcomes
Xavier Paoletti, Adélaïde Doussau, Monia Ezzalfani, et al.
Statistics in Medicine
|
September 17, 2016
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cycles
Jun Yin, Rui Qin, Monia Ezzalfani, et al.
Statistics in Medicine
|
January 22, 2013
Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities
Monia Ezzalfani, Sarah Zohar, Rui Qin, et al.
Plos One
|
September 15, 2021
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project
Monia Ezzalfani, Raphaël Porcher, Alexia Savignoni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
November 11, 2021
rFIXFc prophylaxis improves pain and levels of physical activity in haemophilia B: Post hoc analysis of B-LONG using haemophilia-specific quality of life questionnaires
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Therapeutic Advances in Hematology
|
March 3, 2022
Improvement in pain-related quality of life in patients with hemophilia A treated with rFVIIIFc individualized prophylaxis: post hoc analysis from the A-LONG study
John Pasi, Cédric Hermans, Zalmai Hakimi, et al.
Therapeutic Advances in Hematology
|
June 7, 2023
Recombinant factor IX Fc prophylaxis reduces pain and increases levels of physical activity, with sustained, long-term improvements in patients with hemophilia B:
Jan Astermark, Cédric Hermans, Monia Ezzalfani, et al.
Clinical Pharmacology and Therapeutics
|
February 6, 2021
Antigen Mass May Influence Trastuzumab Concentrations in Cerebrospinal Fluid After Intrathecal Administration
Olivier Le Tilly, Nicolas Azzopardi, Claire Bonneau, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 24, 2020
Combination of Olaparib and Radiation Therapy for Triple Negative Breast Cancer: Preliminary Results of the RADIOPARP Phase 1 Trial
Pierre Loap, Delphine Loirat, Frederique Berger, et al.
Page
of 2